Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991060/ https://www.ncbi.nlm.nih.gov/pubmed/36898405 http://dx.doi.org/10.1016/S1473-3099(23)00132-9 |
_version_ | 1784902064893067264 |
---|---|
author | Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Sakai-Tagawa, Yuko Furusawa, Yuri Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kashima, Yukie Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Suzuki, Yutaka Kawaoka, Yoshihiro |
author_facet | Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Sakai-Tagawa, Yuko Furusawa, Yuri Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kashima, Yukie Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Suzuki, Yutaka Kawaoka, Yoshihiro |
author_sort | Uraki, Ryuta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9991060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99910602023-03-08 Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Sakai-Tagawa, Yuko Furusawa, Yuri Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kashima, Yukie Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Suzuki, Yutaka Kawaoka, Yoshihiro Lancet Infect Dis Correspondence Elsevier Ltd. 2023-05 2023-03-07 /pmc/articles/PMC9991060/ /pubmed/36898405 http://dx.doi.org/10.1016/S1473-3099(23)00132-9 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Sakai-Tagawa, Yuko Furusawa, Yuri Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kashima, Yukie Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Suzuki, Yutaka Kawaoka, Yoshihiro Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title | Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title_full | Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title_fullStr | Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title_full_unstemmed | Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title_short | Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 |
title_sort | efficacy of antivirals and bivalent mrna vaccines against sars-cov-2 isolate ch.1.1 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991060/ https://www.ncbi.nlm.nih.gov/pubmed/36898405 http://dx.doi.org/10.1016/S1473-3099(23)00132-9 |
work_keys_str_mv | AT urakiryuta efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT itomutsumi efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT kisomaki efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT yamayoshiseiya efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT iwatsukihorimotokiyoko efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT sakaitagawayuko efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT furusawayuri efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT imaimasaki efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT kogamichiko efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT yamamotoshinya efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT adachieisuke efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT saitomakoto efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT tsutsumitakeya efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT otaniamato efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT kashimayukie efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT kikuchitetsuhiro efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT yotsuyanagihiroshi efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT suzukiyutaka efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 AT kawaokayoshihiro efficacyofantiviralsandbivalentmrnavaccinesagainstsarscov2isolatech11 |